Evidence map›Paper›PMID 33197266›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2021

Complications related to elective generator replacement of the subcutaneous implantable defibrillator.

Willeke van der Stuijt, Anne-Floor B E Quast, Sarah W E Baalman, Koen C de Wilde, Tom F Brouwer, Arthur A M Wilde, Reinoud E Knops

Open access · hybridAbstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  8. Procedure, management, and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Observational
  9. Systematic Review on S-ICD Lead Extraction.Journal of clinical medicine · 2023
    Review
  10. Review
  11. High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors' reply.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Willeke van der StuijtDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, AMC, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Anne-Floor B E QuastDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, AMC, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Sarah W E BaalmanDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, AMC, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Koen C de WildeDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, AMC, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Tom F BrouwerDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, AMC, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Arthur A M WildeDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, AMC, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Reinoud E KnopsDepartment of Clinical and Experimental Cardiology, Amsterdam UMC, AMC, PO Box 22700, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo guarantee uninterrupted function of the subcutaneous implantable cardioverter-defibrillator (S-ICD), the pulse generator needs to be surgically replaced before the battery is depleted. The risks related to this replacement substantially impact long-term outcome for S-ICD recipients, as the majority will undergo one or several of these procedures in their lifetime. We aim to describe the procedural characteristics of the replacement procedure and to provide an insight in the complications associated with these replacements. METHODS AND

resultsIn this retrospective analysis, data from replacement procedures and follow-up visits were collected from all patients who underwent elective S-ICD generator replacement in our tertiary centre from June 2014 until November 2019. Original device position was assessed using the PRAETORIAN score. Complications were defined as those requiring surgical intervention, systemic antibiotic treatment, or device extraction. Seventy-two patients were included, with a median follow-up of 1.9 years (IQR 0.6-3.3 years) after replacement. Battery depletion occurred after 5.9 ± 0.7 years. The pulse generator was repositioned in patients with a PRAETORIAN score ≥90 to minimize the defibrillation threshold. Although there was an increase in impedance compared to the implant procedure, first shock conversion rate during defibrillation testing was 91.4% with a success rate of 100% after multiple attempts. Two patients developed a complication after, respectively, 9 and 21 months, resulting in a complication rate of 1.4% per year.

conclusionWith a median follow-up of 1.9 years, this study shows a low complication rate after S-ICD replacement, with a first shock conversion rate of 91.4%.

Indexed as

Defibrillators, ImplantableElectric ImpedanceHumansRetrospective StudiesTreatment OutcomeBattery longevityComplication ratePRAETORIAN scorePulse generator replacementShock impedanceSubcutaneous implantable cardioverter-defibrillator

Identifiers

PMID33197266
PMCPMC7947576
OpenAlexW3101782752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.